DUBLIN--(BUSINESS WIRE)--The "Global Peripheral Nerve Stimulators Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
The peripheral nerve stimulators market will register a CAGR of over 5% by 2023.
The high demand for peripheral nerve simulators over oral medications is expected to trigger the market growth during the forecast period.
These simulators reduce or eliminate the use of narcotic drugs. They also allow pain relief by offering target specific treatment in patients with refractory or chronic pain conditions, including complex regional pain syndrome, and cranial neuralgias. Thus, rising demand for peripheral nerve simulators over conventional oral medications will drive the market growth during the forecast period.
Increasing aging population and rising nerve injury cases
The growing older population and rising nerve injury cases are expected to drive the global peripheral nerve stimulators market during the forecast period.
Complications associated with peripheral nerve stimulators
Complications associated with the use of peripheral nerve stimulators include infection, pain, bleeding, allergic reaction, difficulties in relieving pain in large nerve gaps, chances of failure to relieve pain or increase pain, hematoma, and blunt or sharp nerve trauma.
Competitive Landscape
The market appears to be moderately fragmented. PNS manufacturers consistently focusing on innovating products and technologies to enhance their device capabilities, thereby increasing product sales and revenue outcomes.
This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.
Key Players
- Abbott
- Avanos Corporate
- B. Braun Melsungen AG
- Boston Scientific Corp.
- Medtronic
- SPR Therapeutics Inc.
Topics Covered
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
- Comparison by product
- Transcutaneous - Market size and forecast 2018-2023
- Percutaneous - Market size and forecast 2018-2023
- Implantable - Market size and forecast 2018-2023
- Market opportunity by product
PART 07: MARKET SEGMENTATION BY STIMULATING FEATURE
- Comparison by stimulating feature
- PNS-TOF - Market size and forecast 2018-2023
- PNS - Market size and forecast 2018-2023
- Market opportunity by stimulating feature
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- RoW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
PART 12: MARKET TRENDS
- Technological advances
- Wireless PNS
- Industry developments
PART 13: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 14: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Abbott
- Avanos Corporate
- B. Braun Melsungen AG
- Boston Scientific Corp.
- Medtronic
- SPR Therapeutics Inc.
For more information about this report visit https://www.researchandmarkets.com/r/9qun14
